In the News

Surgeons and Spine Societies Increase Patient Access to Barricaid® for Discectomy Surgery Following Recent Coding Successes and Recognition in Updated Guidelines

Intrinsic Therapeutics Offers Virtual and Hands-On Training Sessions as Elective Surgeries Resume – via PR Newswire WOBURN, Mass., June 2, 2020 – Intrinsic Therapeutics, Inc., a medical device company focused on delivering safe treatments to improve surgical efficacy, today announced growing enthusiasm among physicians for its Barricaid technology, which manages lumbar disc herniation.  While elective […]

Read more

COVID-19 Company Update

“The measure of intelligence is the ability to change.” ― Albert Einstein. While this unprecedented time has forced us all to make changes and sacrifices, the Intrinsic team is using the time to learn and adopt innovative ways to educate and train the medical and patient communities on the impact Barricaid can have in managing lumbar […]

Read more

Annular Closure a Key Topic in latest Int Journal of Spine Surgery

Barricaid and the topic of annular closure for herniated disc patients feature in two articles in the most recent issue by IJSS, the International Journal of Spine Surgery. This journal is the official publication of ISASS, the International Society for the Advancement of Spine Surgery. ISASS is among the largest societies of spine surgeons, and […]

Read more

Recap of a successful inaugural U.S. Disc Collective Meeting

New York NY, January 2020 – Intrinsic Therapeutics hosted its first U.S. Disc Collective Meeting on 16-17 January, 2020 in Manhattan, New York. 15 spine surgeons travelled to the East Coast in order to learn more about and exchange experiences on the topic of lumbar disc herniation.  The program was themed around “A future of […]

Read more

Barricaid maker Intrinsic Therapeutics among top 20 private medtech companies

The Barricaid team is proud to be ranked among the top 20 private medtech companies to watch in 2020 by MDDI (Medical Device and Diagnostic Industry). To our mission, we stay committed to reducing needless suffering by ensuring Barricaid Annular Closure is accessible to patients and surgeons. Intrinsic Therapeutics’ Barricaid device is the only FDA […]

Read more

Study in Spine: Annular Closure Device Good Option

On Tuesday, January 8th, 2019, Orthopedics This Week reports about a multicenter study from Northwestern University, The University of California-Davis, and the OLVG Hospital in Amsterdam, that has looked into costs associated with employing the Barricaid annular closure device for patients who are at high risk for recurrent herniation after a discectomy. Their work, “Cost-effectiveness of a bone-anchored annular […]

Read more

Barricaid superiority data presented at 25th Brussels international spine symposium

The Brussels International Spine Symposium (BISS) is globally recognized as one of the world leading, state-of-art annual meetings in Spine. Under the auspice of Drs. Marek Szpalski and Robert Gunzburg, the 25th anniversary meeting took place on 16-17 November 2018 reviewing the topic of Disc Herniation – Back to Basics: Controversies in diagnosis, management and costs. One […]

Read more

Landmark study published in the spine journal: annular closure superior to standard of care

The two-year results from a Level 1, randomized superiority study were published in The Spine Journal. Results from this landmark clinical study, that includes 554 patients from 6 countries, demonstrate superior outcomes when treating patients with large annular defects with Barricaid Annular Closure compared to discectomy alone. ABSTRACT SUMMARY Background context: Patients with large annular defects following […]

Read more

Best Paper Award SSA 2018 presented to Dr. Mark Arts

Dr. Mark Arts, a Dutch neurosurgeon from The Hague, delivered two podium presentations at the 2018 Spine Society of Australia 29th Annual Scientific Meeting, 27-29 April in Adelaide. One of his presented abstracts was elected as Best Paper of the 2018 Annual Scientific Meeting. Both talks were delivered in the Free Paper Session that focused on […]

Read more

If Barricaid is right for you, we can help.

Sign up to receive future updates and information on the Barricaid procedure.
  • This field is for validation purposes and should be left unchanged.